특허 및 논문

바이오솔빅스에 자료실을 확인해 보세요.
bt_bb_section_bottom_section_coverage_image

BIOSOLVIX ARCHIVE특허 및 논문

Blue laser-induced selective vasorelaxation by the activation of NOSs.

작성자
관리자
작성일
2024-02-01 22:22
조회
243

Park SW*, Park SJ*, Choi HK, Park HJ, Yu WJ, Kim HS, Jeon MN, Chung SC, Ban KW, Moon SH*, Bae YM*. Blue laser-induced selective vasorelaxation by the activation of NOSs. Microvascular Research.2021.136:104165.


Abstract



Phototherapy has been tried for treating cardiovascular diseases. In particular, ultraviolet and blue visible lights were suggested to be useful due to their nitric oxide (NO)-production ability in the skin. However, the effects of blue light on the arterial contractility are controversial. Here, we hypothesized that appropriate protocol of blue laser can induce selective vasorelaxation by activating vasodilating signaling molecules in arteries. Using organ chamber arterial mechanics, NO assay, Matrigel assay, and microarray, we showed that a 200-Hz, 300-μs, 445-nm pulsed-laser (total energy of 600 mJ; spot size 4 mm) induced selective vasorelaxation, without vasocontraction in rat mesenteric arteries. The laser stimulation increased NO production in the cord blood-endothelial progenitor cells (CB-EPCs). Both the laser-induced vasorelaxation and NO production were inhibited by a non-selective, pan-NO synthase inhibitor, L-NG-Nitro arginine methyl ester. Microarray study in CB-EPCs suggested up-regulation of cryptochrome (CRY)2 as well as NO synthase (NOS)1 and NOSTRIN (NOS trafficking) by the laser. In conclusion, this study suggests that the 445-nm blue puled-laser can induce vasorelaxation possibly via the CRY photoreceptors and NOSs activation. The blue laser-therapy would be useful for treating systemic hypertension as well as improving local blood flow depending on the area of irradiation.


Keywords: #445 nm laser #Cryptochrome #NOS #Phototherapy #Vessel relaxation.

 

논문확인(클릭시 이동) 
전체 52
번호 제목 작성자 작성일 추천 조회
42
Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors.
관리자 | 2024.02.02 | 추천 0 | 조회 233
관리자 2024.02.02 0 233
41
In silico design and fabrication of an SFI chip-based microspheroid culture system.
관리자 | 2024.02.02 | 추천 0 | 조회 291
관리자 2024.02.02 0 291
40
Effect and application of cryopreserved three-dimensional microcardiac spheroids in myocardial infarction therapy
관리자 | 2024.02.01 | 추천 0 | 조회 233
관리자 2024.02.01 0 233
39
Blue laser-induced selective vasorelaxation by the activation of NOSs.
관리자 | 2024.02.01 | 추천 0 | 조회 243
관리자 2024.02.01 0 243
38
Therapeutic Efficacy of Artificial Skin Produced by 3D Bioprinting.
관리자 | 2024.02.01 | 추천 0 | 조회 268
관리자 2024.02.01 0 268
37
Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization  international pharmacov
관리자 | 2024.02.01 | 추천 0 | 조회 239
관리자 2024.02.01 0 239
36
Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models vi
관리자 | 2024.02.01 | 추천 0 | 조회 230
관리자 2024.02.01 0 230
35
Application of co-culture technology of epithelial type cells and mesenchymal type cells using nanopatterned structures
관리자 | 2024.02.01 | 추천 0 | 조회 265
관리자 2024.02.01 0 265
34
Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivat
관리자 | 2024.02.01 | 추천 0 | 조회 289
관리자 2024.02.01 0 289
33
Antiviral activity and safety of remdesivir against SARS-CoV- 2 infection in human pluripotent stem cell-derived cardiomyocytes
관리자 | 2024.02.01 | 추천 0 | 조회 250
관리자 2024.02.01 0 250